Anthem Blue Cross Blue Shield of Indiana policy
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy is a public Anthem Blue Cross Blue Shield of Indiana policy (policy LAB.00042). It lists 1 CPT or HCPCS code. Not a coverage decision; the payer's own document governs.
- Policy number
- LAB.00042
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes.
| Code | Other Anthem Blue Cross Blue Shield of Indiana policies |
|---|---|
| 81599 | Policies naming 81599 |